Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Nurs Res. 2022 Dec 9;72(2):103–113. doi: 10.1097/NNR.0000000000000636

Table 3.

Symptom Burden Overall and by Race/Ethnicity

Symptom Burden Entire sample N = 400 Hispanic, n = 168 Non-Hispanic White, n = 191 Non-Hispanic other races, n = 41 p
Mean (SD) Prevalence N (%) Mean (SD) Mean (SD) Mean (SD)
Depressive symptomsa 16.89 (11.58) N/A 17.88 (12.55) 15.27 (10.29) 20.42 (12.18) .01
Anxietyb 53.27 (10.48) N/A 53.95 (11.09) 52.18 (9.69) 55.62 (11.14) .09
Summed symptom severity indexc 41.11 (24.55) N/A 43.67 (26.29) 36.20 (20.44) 53.83 (29.15) <.01
Number of symptomsd 9.73 (3.73) N/A 9.75 (3.95) 9.39 (3.42) 11.30 (3.89) .01
Fatiguee 4.91 (2.95) 358 (90%) 4.61 (3.17) 4.96 (2.76) 5.90 (2.68) .04
Pain 3.92 (3.31) 296 (74%) 4.23 (3.43) 3.14 (3.09) 5.45 (3.17) <.01
Sleep difficulties 4.39 (3.22) 322 (81%) 4.64 (3.38) 3.95 (3.08) 5.48 (2.93) <.01
Headache 2.08 (2.69) 204 (51%) 2.50 (2.82) 1.58 (2.38) 2.75 (3.15) <.01
Difficulty concentrating 3.44 (2.97) 297 (75%) 3.53 (3.24) 3.19 (2.71) 4.25 (2.97) .11
Lack of appetite 2.40 (2.95) 208 (52%) 2.50 (3.00) 2.08 (2.79) 3.53 (3.22) .02
Nausea 2.01 (2.88) 184 (46%) 2.56 (3.16) 1.30 (2.22) 3.03 (3.61) <.01
Vomiting 0.72 (2.07) 67 (17%) 1.07 (2.37) 0.25 (1.15) 1.48 (3.32) <.01
Constipation 2.35 (3.14) 195 (49%) 3.18 (3.53) 1.49 (2.43) 2.98 (3.39) <.01
Diarrhea 1.43 (2.53) 142 (36%) 1.11 (2.36) 1.68 (2.64) 1.60 (2.62) .09
Numbness or tingling 3.27 (3.27) 254 (64%) 3.68 (3.34) 2.77 (3.16) 3.93 (3.27) .01
Swelling 1.93 (2.87) 164 (41%) 1.90 (2.84) 1.80 (2.80) 2.73 (3.21) .17
Weakness 3.57 (3.14) 288 (72%) 3.65 (3.24) 3.24 (2.98) 4.80 (3.17) .01
Shortness of breath 1.85 (2.73) 178 (45%) 1.68 (2.56) 1.82 (2.72) 2.68 (3.78) .12
Cough 1.47 (2.52) 151 (38%) 1.50 (2.46) 1.47 (2.61) 1.38 (2.40) .96
Depression 2.87 (3.07) 257 (65%) 2.95 (3.23) 2.60 (2.80) 3.88 (3.40) .05
Anxiety 3.89 (3.11) 309 (78%) 3.87 (3.36) 3.82 (2.95) 4.35 (2.89) .62

Note.

a

Center for Epidemiological-Depression scale (CES-D)-potential range 0–60, higher score = worse depression;

b

Anxiety Patient Reported Outcomes Measurement Information System (PROMIS)-T scores range 43.2–83.1, higher score = more anxiety;

c

Summed symptom severity-potential range 0–150, without depression and anxiety, higher score = greater severity;

d

number of symptoms-potential range 0–17, includes depression and anxiety, higher score = more symptoms;

e

All symptoms (Fatigue-Anxiety) scored on 0–10 scale-higher score=more distressing/severe the symptom